Close mobile menu×
Close mobile menu

Larisa J. Geskin, MD

Board Certifications: 
Dermatology
Expertise in: 
Skin Cancer, Melanoma, Cancer Care
Accepting New Patients
Profile Headshot

Appointments

Book Online

Participating DocASAP doctors have online booking available without the need for a myColumbiaDoctors account.

Phone Appointments

New and Existing Patients: 
(212) 305-5293

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor

Board Certifications

  • Dermatology

Clinical Expertise

  • Skin Cancer
  • Melanoma
  • Cancer Care
  • Skin Cancer Surgery
  • Skin Cancer
  • Cutaneous Lymphoma
  • General dermatology
  • Non-Melanoma Skin Cancer
  • Dermatologic Oncology

Education & Training

  • 1995 Albert Einstein College of Medicine
  • MD, University of Pittsburgh School Of Medicine
  • Residency: 2001 University of Pittsburgh Medical Center
  • Fellowship: 2003 University of Pittsburgh Medical Center

About Larisa Geskin

Dr. Larisa Geskin, MD – Dermatologist at ColumbiaDoctors

Dr. Larisa Geskin is an Associate Professor of Dermatology at Columbia University Medical Center and Director of the Comprehensive Skin Cancer Center (CSCC) at the Division of Cutaneous Oncology in the Department of Dermatology.

She is a world-renowned specialist in the diagnosis and management of cutaneous lymphomas and other cancers of the skin. Her other areas of expertise include melanoma screening, prevention, medical and surgical therapy, and management of high risk for skin cancer populations. Dr. Geskin is using state-of-the-art methods in melanoma screening and surveillance including Mole Mapping (body mapping) and dermoscopy. She was involved in development of novel melanoma detection methods, including MelaFind among others. Dr. Geskin's team aims to provide multidisciplinary care to skin cancer patients, to conduct cutting edge clinical and basic science research, and to train medical students, residents and fellows in the area of cutaneous oncology.

Dr. Geskin completed her residency in Dermatology at University of Pittsburgh Medical Center (UPMC), and a two-year fellowship in cutaneous oncology at University of Pittsburgh Cancer Institute (UPCI) with Louis Falo, MD, PhD, Professor and Chairman, Department of Dermatology, UPMC, and with John Kirkwood, MD, Professor and Vice Chairman for Clinical Research, Director of the Melanoma Center at the UPCI.

She is a diplomat of the American Academy of Dermatology, member of the Society for Investigative Dermatology, the International Society for Cutaneous Lymphomas, and US Cutaneous Lymphomas Consortium. She authored over 30 peer-reviewed articles in the field of cutaneous oncology. Her research interest focuses on Cutaneous T-cell lymphoma (CTCL) and biomarkers discovery, genetic profiling and regulation, development of immunotherapy for melanoma and lymphoma.

Academic Titles

  • Associate Professor of Dermatology (in Medicine) at CUMC

Administrative Positions

  • Director, Cutaneous Oncology

Hospital Affiliations

  • NewYork-Presbyterian/Columbia
  • NewYork-Presbyterian/Lawrence Hospital

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
161 Fort Washington Avenue
New York, New York 10032
Phone:
(212) 305-5293
Fax:
(212) 795-1859
Primary
2
51 West 51st Street
Suite 390
New York, New York 10019
Phone:
(212) 305-5293
Fax:
(212) 326-8567

Research

Grants

A PHASE 3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO DETERMINE THE EFFICACY OF TOPICAL SGX301 (SYNTHETIC HYPERICIN) AND FLUORESCENT BULB-LIGHT IRRADIATION FOR THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA (P&S Industry Clinical Trial)

May 1 2017 - May 30 2022

A DOUBLE BLIND, RANDOMIZED, VEHICLE CONTROLLED, CROSSOVER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TOPICAL NALOXONE HYDROCHLORIDE LOTION, 0.5%, FOR THE RELIEF OF PRURITUS IN PATIENTS WITH THE MYCOSIS FUNGOIDES (MF) FORM OF CUTANEOUS (P&S Industry Clinical Trial)

Mar 8 2017 - Mar 8 2022

ROLE OF THE TOX-RUNX3 PATHWAY IN CUTANEOUS T-CELL LYMPHOMA (Private)

May 1 2017 - Apr 30 2018

A MULTIPLEX ASSAY FOR EARLY DETECTION OF CUTANEOUS T-CELL LYMPHOMA (Federal Gov)

Sep 1 2016 - Aug 31 2017

MOLECULAR PATHWAYS OF INERLEUKIN-13 IN CUTANEOUS T-CELL LYMPHOMA (Federal Gov)

Jul 1 2016 - Jun 30 2017

IDENTIFYING LONG NON-CODING RNAS THAT FUNCTION AS MICRORNA SPONGES DURING MELANOMA INITIATION (Private)

Feb 1 2016 - Jan 31 2017